Please enable / Bitte aktiviere JavaScript!
Veuillez activer / Por favor activa el Javascript!

“Three U.S. senators ask Mylan for EpiPen military reimbursements” plus 9 more Reuters: Health News

loading...

“Three U.S. senators ask Mylan for EpiPen military reimbursements” plus 9 more Reuters: Health News


Three U.S. senators ask Mylan for EpiPen military reimbursements

Posted: 07 Nov 2016 02:34 PM PST

(Reuters) - Three members of the U.S. Senate Judiciary Committee, ahead of a planned hearing late this month, said Mylan NV appears to have greatly overcharged the military for its lifesaving allergy treatment EpiPen and asked the pharmaceutical company when it plans to reimburse the Department of Defense.

Bayer applies for Regorafenib authorization to treat liver cancer

Posted: 07 Nov 2016 01:00 AM PST

FRANKFURT (Reuters) - German drugmaker Bayer on Monday said it submitted an application to have its cancer drug Regorafenib approved for the second-line treatment of liver cancer patients following successful clinical trials.

Roche says flexible pricing ready for cancer, not MS drugs

Posted: 07 Nov 2016 03:12 PM PST

ZURICH (Reuters) - The spotlight on finding a cancer cure has spurred improvements in systems to collect and analyze oncology data, but efforts to track patients with other diseases lag behind, Roche pricing head Jens Grueger said.

Stanford uses CRISPR to correct sickle cell, human trials planned

Posted: 07 Nov 2016 04:03 PM PST

CHICAGO (Reuters) - Scientists at Stanford University School of Medicine have used the CRISPR gene editing tool to repair the gene that causes sickle cell disease in stem cells from diseased patients, paving the way for a potential cure for the disease, which affects up to 5 million people globally.

Childhood cancer survivors have lasting health problems even with newer treatments

Posted: 07 Nov 2016 04:50 PM PST

(Reuters Health) - Despite advances that have made treatments safer and more effective, childhood cancer survivors don't appear to have experienced gains in long-term health outcomes, a new study suggests.

British American Tobacco to test tobacco e-cigarette in Japan

Posted: 08 Nov 2016 12:07 AM PST

TOKYO/LONDON (Reuters) - British American Tobacco PLC (BAT) plans to test a new tobacco-based cigarette alternative in Japan next month, it said on Tuesday, taking aim at Philip Morris International Inc's popular iQOS and Japan Tobacco Inc's Ploom Tech.

Anesthesia before age 4 may have small effect on academics later

Posted: 07 Nov 2016 10:36 AM PST

(Reuters Health) - Kids who are exposed to surgical anesthesia before age four tend to have slightly lower school grades at age 16 compared to other kids, but the difference is very small and shouldn't discourage parents from proceeding with necessary surgeries, researchers say.

Roche advances skin cancer trials as part of combination therapy strategy

Posted: 07 Nov 2016 01:06 AM PST

ZURICH (Reuters) - Roche is pressing ahead with two skin cancer trials that combine its immunotherapy Tecentriq with other drugs after early data showed the treatments were well-tolerated and effective in a small number of patients, the company said Monday.

'Lazy mosquitoes' mean more women than men get chikungunya: scientists

Posted: 07 Nov 2016 05:20 PM PST

LONDON (Thomson Reuters Foundation) - "Lazy mosquitoes" are the reason why women, who tend to spend more time at home than men, are more likely to be infected by chikungunya, a painful mosquito-borne viral disease which spreads the same way as Zika, researchers said on Monday.

Monthly cost of providing key drugs could be $1-2 per person: experts

Posted: 07 Nov 2016 05:22 PM PST

LONDON (Thomson Reuters Foundation) - Essential medicines could be provided for as little as $1-$2 a month per person in developing countries, experts said on Monday as they called on governments to boost efforts to ensure everyone can access basic healthcare.

Related Posts :